Literature DB >> 10964564

The Saccharomyces cerevisiae homologue YPA1 of the mammalian phosphotyrosyl phosphatase activator of protein phosphatase 2A controls progression through the G1 phase of the yeast cell cycle.

C Van Hoof1, V Janssens, I De Baere, J H de Winde, J Winderickx, F Dumortier, J M Thevelein, W Merlevede, J Goris.   

Abstract

The Saccharomyces cerevisiae gene YPA1 encodes a protein homologous to the phosphotyrosyl phosphatase activator, PTPA, of the mammalian protein phosphatase type 2A (PP2A). In order to examine the biological role of PTPA, we disrupted YPA1 and characterised the phenotype of the ypa1Delta mutant. Comparison of the growth rate of the wild-type strain and the ypa1Delta mutant on glucose-rich medium after nutrient depletion showed that the ypa1Delta mutant traversed the lag period more rapidly. This accelerated progression through "Start" was also observed after release from alpha-factor-induced G1 arrest as evidenced by a higher number of budding cells, a faster increase in CLN2 mRNA expression and a more rapid reactivation of Cdc28 kinase activity. This phenotype was specific for deletion of YPA1 since it was not observed when YPA2, the second PTPA gene in budding yeast was deleted. Reintroduction of YPA1 or the human PTPA cDNA in the ypa1Delta mutant suppressed this phenotype as opposed to overexpression of YPA2. Disruption of both YPA genes is lethal, since sporulation of heterozygous diploids resulted in at most three viable spores, none of them with a ypa1Delta ypa2Delta genotype. This observation indicates that YPA1 and YPA2 share some essential functions. We compared the ypa1Delta mutant phenotype with a PP2A double deletion mutant and a PP2A temperature-sensitive mutant. The PP2A-deficient yeast strain also showed accelerated progression through the G1 phase. In addition, both PP2A and ypa1Delta mutants show similar aberrant bud morphology. This would support the notion that YPA1 may act as a positive regulator of PP2A in vivo. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964564     DOI: 10.1006/jmbi.2000.4062

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  Specific interactions of PP2A and PP2A-like phosphatases with the yeast PTPA homologues, Ypa1 and Ypa2.

Authors:  Christine Van Hoof; Ellen Martens; Sari Longin; Jan Jordens; Ilse Stevens; Veerle Janssens; Jozef Goris
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

2.  De novo telomere formation is suppressed by the Mec1-dependent inhibition of Cdc13 accumulation at DNA breaks.

Authors:  Wei Zhang; Daniel Durocher
Journal:  Genes Dev       Date:  2010-03-01       Impact factor: 11.361

3.  Characterization of ypa1 and ypa2, the Schizosaccharomyces pombe orthologs of the peptidyl proyl isomerases that activate PP2A, reveals a role for Ypa2p in the regulation of cytokinesis.

Authors:  Anupama Goyal; Viesturs Simanis
Journal:  Genetics       Date:  2012-01-20       Impact factor: 4.562

4.  The yeast phosphotyrosyl phosphatase activator is part of the Tap42-phosphatase complexes.

Authors:  Yin Zheng; Yu Jiang
Journal:  Mol Biol Cell       Date:  2005-02-02       Impact factor: 4.138

Review 5.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.

Authors:  V Janssens; J Goris
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

6.  An inactive protein phosphatase 2A population is associated with methylesterase and can be re-activated by the phosphotyrosyl phosphatase activator.

Authors:  Sari Longin; Jan Jordens; Ellen Martens; Ilse Stevens; Veerle Janssens; Evelien Rondelez; Ivo De Baere; Rita Derua; Etienne Waelkens; Jozef Goris; Christine Van Hoof
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

7.  PhosphoTyrosyl phosphatase activator of Plasmodium falciparum: identification of its residues involved in binding to and activation of PP2A.

Authors:  Audrey Vandomme; Aline Fréville; Katia Cailliau; Hadidjatou Kalamou; Jean-François Bodart; Jamal Khalife; Christine Pierrot
Journal:  Int J Mol Sci       Date:  2014-02-11       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.